Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the Nanopatch^TM Microneedle Delivery System

References

• Horikami SM, Moyer SA. Structure, Transcription, and Replication of Measles Virus. In: Ter Meulen V, Billeter MA, editors. Measles Virus. Berlin (Heidelberg): Springer Berlin Heidelberg; 1995. p. 35–50.
   Google Scholar
• Frey TK. Molecular biology of rubella virus. Adv Virus Res. 1994;44:69–160.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Measles vaccines: WHO position paper; 2017 [accessed 17 Jan 2021]. https://apps.who.int/iris/bitstream/handle/10665/255149/WER9217.pdf?sequence=1.
   Google Scholar
• World Health Organization. Rubella vaccines: WHO position paper; 2020 [accessed 17 Jan 2021]. https://apps.who.int/iris/bitstream/handle/10665/332950/WER9527-eng-fre.pdf?ua=1.
   Google Scholar
• Kowalzik F, Faber J, Knuf M. MMR and MMRV vaccines. Vaccine. 2018;36(36):5402–07. doi:10.1016/j.vaccine.2017.07.051.
   PubMed Web of Science ®Google Scholar
• Masters NB, Wagner AL, Ding Y, Zhang Y, Boulton ML. Assessing measles vaccine failure in Tianjin, China. Vaccine. 2019;37(25):3251–54. doi:10.1016/j.vaccine.2019.05.005.
   PubMed Web of Science ®Google Scholar
• Orenstein WA, Cairns L, Hinman  A, Nkowane B, Olivé JM, Reingold AL. Measles and Rubella Global Strategic Plan 2012–2020 midterm review report: Background and summary. Vaccine. 2018;36(Supplement 1):A35–A42. doi:10.1016/j.vaccine.2017.10.065.
   Google Scholar
• Orenstein WA, Cairns L, Hinman A, Nkowane B, Olivé JM, Reingold AL. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: background and summary. Vaccine. 2018;36(Suppl 1):A35–a42. doi:10.1016/j.vaccine.2017.10.065.
   PubMed Web of Science ®Google Scholar
• Gomez PL, Robinson JM. Vaccine Manufacturing. Plotkin’s Vaccines. 2017;51–60.e1.
   Google Scholar
• Wang B, Hu L, Siahaan TJ. Drug Delivery: principles and Applications. 2nd ed. Hoboken (NJ): John Wiley & Sons, Inc; 2016.
   Google Scholar
• Sahni N, Cheng Y, Middaugh CR, Volkin DB. Vaccine Delivery: current Routes of Administration and Novel Approaches. In: Wang B, Hu L, Siahaan TJ, editors. Drug Delivery. Hoboken (NJ): John Wiley & Sons, Inc; 2016. p. 623–54.
   Google Scholar
• Temperature sensitivity of vaccines/WHO/IVB/06.10; 2006.
   Google Scholar
• Forster AH, Witham K, Depelsenaire ACI, Veitch M, Wells JW, Wheatley A, Pryor M, Lickliter JD, Francis B, Rockman S, et al. Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: results from a randomized, controlled phase I clinical trial. PLoS Med. 2020;17(3):e1003024. doi:10.1371/journal.pmed.1003024.
   PubMed Web of Science ®Google Scholar
• Meyer BK, Kendall MAF, Williams DM, Bett AJ, Dubey S, Gentzel RC, Casimirod D, Forster A, Corbett H, Crichton M, et al. Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: an exploratory, pre-clinical feasibility assessment. Vaccine. 2019;2:100030. doi:10.1016/j.jvacx.2019.100030.
   Web of Science ®Google Scholar
• Fernando GJP, Hickling J, Jayashi Flores CM, Griffin P, Anderson CD, Skinner SR, Davies C, Witham K, Pryor M, Bodle J, et al. Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™). Vaccine. 2018;36(26):3779–88. doi:10.1016/j.vaccine.2018.05.053.
   PubMed Web of Science ®Google Scholar
• Griffin P, Elliott S, Krauer K, Davies C, Skinner SR, Anderson CD, Forster A. Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjects. Vaccine. 2017;35(48):6676–84. doi:10.1016/j.vaccine.2017.10.021.
   PubMed Web of Science ®Google Scholar
• Muller DA, Pearson FE, Fernando GJP, Agyei-Yeboah C, Owens NS, Corrie SR, Crichton ML, Wei JCJ, Weldon WC, Oberste MS, et al. Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses. Sci Rep. 2016;6(1):22094. doi:10.1038/srep22094.
   PubMed Web of Science ®Google Scholar
• Fernando GJ, Zhang J, Ng HI, Haigh OL, Yukiko SR, Kendall MA. Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses. J Control Release. 2016;237:35–41. doi:10.1016/j.jconrel.2016.06.045.
   PubMed Web of Science ®Google Scholar
• Mistilis MJ, Bommarius AS, Prausnitz MR. Development of a Thermostable Microneedle Patch for Influenza Vaccination. J Pharm Sci. 2015;104(2):740–49. doi:10.1002/jps.24283.
   PubMed Web of Science ®Google Scholar
• Edens C, Dybdahl-Sissoko NC, Weldon WC, Oberste MS, Prausnitz MR. Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque. Vaccine. 2015;33(37):4683–90. doi:10.1016/j.vaccine.2015.01.089.
   PubMed Web of Science ®Google Scholar
• Edens C, Collins ML, Goodson JL, Rota PA, Prausnitz MR. A Microneedle Patch Containing Measles Vaccine is Immunogenic in Non-human Primates. Vaccine. 2015;33(37):4712–18. doi:10.1016/j.vaccine.2015.02.074.
   PubMed Web of Science ®Google Scholar
• Bonificio A, Ghartey-Tagoe E, Gallorini S, Baudner B, Chen G, Singh P, O’Hagana DT, Kommareddy S. Fabrication of cell culture-derived influenza vaccine dissolvable microstructures and evaluation of immunogenicity in guinea pigs. Vaccine. 2015;33(25):2930–38. doi:10.1016/j.vaccine.2015.04.059.
   PubMed Web of Science ®Google Scholar
• McNeilly CL, Crichton ML, Primiero CA, Frazer IH, Roberts MS, Kendall MAF. Microprojection arrays to immunise at mucosal surfaces. J Control Release. 2014;196:252–60. doi:10.1016/j.jconrel.2014.09.028.
   PubMed Web of Science ®Google Scholar
• Depelsenaire ACI, Meliga SC, McNeilly CL, Pearson FE, Coffey JW, Haigh OL,Flaim CJ, Frazer IH, Kendall MAF. Co-localization of cell death with antigen deposition in skin enhances vaccine immunogenicity. J Invest Dermatol. 2014;134(9):2361–70. doi:10.1038/jid.2014.174.
   PubMed Web of Science ®Google Scholar
• Carey JB, Vrdoljak A, O’Mahony C, Hill AVS, Draper SJ, Moore AC. Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route. Sci Rep. 2014;4:6154. doi:10.1038/srep06154.
   PubMed Web of Science ®Google Scholar
• Pearson FE, McNeilly CL, Crichton ML, Primiero CA, Yukiko SR, Fernando GJ, Chen X, Gilbert SC, Hill AVS, Kendall MAF Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice. PLoS One. 2013;8(7):e67888. doi:10.1371/journal.pone.0067888.
   PubMed Web of Science ®Google Scholar
• Edens C, Collins ML, Ayers J, Rota PA, Prausnitz MR. Measles vaccination using a microneedle patch. Vaccine. 2013;31(34):3403–09. doi:10.1016/j.vaccine.2012.09.062.
   PubMed Web of Science ®Google Scholar
• Koutsonanos DG, Vassilieva EV, Stavropoulou A, Zarnitsyn VG, Esser ES, Taherbhai MT, Prausnitz MR, Compans RW, Skountzou I. Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection. Sci Rep. 2012;2(1):357. doi:10.1038/srep00357.
   PubMedGoogle Scholar
• Raphael AP, Prow TW, Crichton ML, Chen X, Fernando GJ, Kendall MA. Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays. Small (Weinheim an Der Bergstrasse, Germany). 2010;6(16):1785–93. doi:10.1002/smll.201000326.
   PubMed Web of Science ®Google Scholar
• Prow TW, Chen X, Prow NA, Fernando GJ, Tan CS, Raphael AP,  Chang D, Ruutu MP, Jenkins DWK, Pyke A, et al. Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. Small (Weinheim an Der Bergstrasse, Germany). 2010;6(16):1776–84. doi:10.1002/smll.201000331.
   PubMed Web of Science ®Google Scholar
• Wan Y, Hickey JM, Bird C, Witham K, Fahey P, Forster A, Joshi SB, Volkin DB. Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection Array. J Pharm Sci. 2018;107(6):1540–51. doi:10.1016/j.xphs.2018.01.027.
   PubMed Web of Science ®Google Scholar
• Joyce JC, Carroll TD, Collins ML, Chen MH, Fritts L, Dutra JC, Rourke TL, Goodson JL, McChesney MB, Prausnitz MR, et al. A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques. J Infect Dis. 2018;218(1):124–32. doi:10.1093/infdis/jiy139.
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Goodson JL, Rota PA, Orenstein WA. A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination. Curr Opin Virol. 2020;41:68–76. doi:10.1016/j.coviro.2020.05.005.
   PubMed Web of Science ®Google Scholar
• Richardson LC, Moss WJ. Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa. Pan Afr Med J. 2020;35(Supp 1):3. doi:10.11604/pamj.supp.2020.35.1.19753.
   PubMedGoogle Scholar
• Zehrung D. Microarray patch case study: measles-rubella vaccine; 2016.
   Google Scholar
• Pearson FE, Muller DA, Roalfe L, Zancolli M, Goldblatt D, Kendall MA. Functional anti-polysaccharide IgG titres induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patch. Vaccine. 2015;33(48):6675–83. doi:10.1016/j.vaccine.2015.10.081.
   PubMed Web of Science ®Google Scholar
• Crichton ML, Ansaldo A, Chen X, Prow TW, Fernando GJP, Kendall MAF. The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine. Biomaterials. 2010;31(16):4562–72. doi:10.1016/j.biomaterials.2010.02.022.
   PubMed Web of Science ®Google Scholar
• Crichton ML, Muller DA, Depelsenaire ACI, Pearson FE, Wei J, Coffey J, Zhang J, Fernando GJP, Kendall MAF. The changing shape of vaccination: improving immune responses through geometrical variations of a microdevice for immunization. Sci Rep. 2016;6(1):27217. doi:10.1038/srep27217.
   PubMedGoogle Scholar
• Ammour Y, Faizuloev E, Borisova T, Nikonova A, Dmitriev G, Lobodanov S, Zverev V. Quantification of measles, mumps and rubella viruses using real-time quantitative TaqMan-based RT-PCR assay. J Virol Methods. 2013;187(1):57–64. doi:10.1016/j.jviromet.2012.09.011.
   PubMed Web of Science ®Google Scholar
• Wang F, Puddy AC, Mathis BC, Montalvo AG, Louis AA, McMackin JL, Xu J, Zhang Y, Tan CY, Schofield TL, et al. Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency. Vaccine. 2005;23(36):4500–08. doi:10.1016/j.vaccine.2005.04.023.
   PubMed Web of Science ®Google Scholar
• Schalk JAC, de Vries CGJCA, Jongen PMJM. Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay. Biologicals. 2005;33(2):71–79. doi:10.1016/j.biologicals.2005.01.001.
   PubMed Web of Science ®Google Scholar
• Schalk JA, van den Elzen C, Ovelgonne H, Baas C, Jongen PM. Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR. J Virol Methods. 2004;117(2):179–87. doi:10.1016/j.jviromet.2004.01.009.
   PubMed Web of Science ®Google Scholar
• Manual of laboratory methods for testing of vaccines used in the WHO expanded programme on immunization/WHO/VSQ/97.04; 1997.
   Google Scholar
• Vieyres G, Pietschmann T. Entry and replication of recombinant hepatitis C viruses in cell culture. Methods. 2013;59(2):233–48. doi:10.1016/j.ymeth.2012.09.005.
   PubMed Web of Science ®Google Scholar
• Roy F, Mendoza L, Hiebert J, McNall RJ, Bankamp B, Connolly S, Lüdde A, Friedrich N, Mankertz A, Rota PA, et al. Rapid Identification of Measles Virus Vaccine Genotype by Real-Time PCR. J Clin Microbiol. 2017;55(3):735–43. doi:10.1128/JCM.01879-16.
   PubMed Web of Science ®Google Scholar
• Claus C, Bergs S, Emmrich NC, Hubschen JM, Mankertz A, Liebert UG. A sensitive one-step TaqMan amplification approach for detection of rubella virus clade I and II genotypes in clinical samples. Arch Virol. 2017;162(2):477–86. doi:10.1007/s00705-016-3131-1.
   PubMed Web of Science ®Google Scholar
• Hübschen JM, Kremer JR, De Landtsheer S, Muller CP. A multiplex TaqMan PCR assay for the detection of measles and rubella virus. J Virol Methods. 2008;149(2):246–50. doi:10.1016/j.jviromet.2008.01.032.
   PubMed Web of Science ®Google Scholar
• Ranheim T, Mathis PK, Joelsson DB, Smith ME, Campbell KM, Lucas G, Barmat S, Melissen E, Benz R, Lewis JA, et al. Development and application of a quantitative RT-PCR potency assay for a pentavalent rotavirus vaccine (RotaTeq). J Virol Methods. 2006;131(2):193–201. doi:10.1016/j.jviromet.2005.08.013.
   PubMed Web of Science ®Google Scholar
• Hummel KB, Lowe L, Bellini WJ, Rota PA. Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens. J Virol Methods. 2006;132(1–2):166–73. doi:10.1016/j.jviromet.2005.10.006.
   PubMed Web of Science ®Google Scholar
• Mukaka MM. Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012;24(3):69–71.
   Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Inactive Ingredient Search for Approved Drug Products. [accessed 17 Jan 2021]. https://www.accessdata.fda.gov/scripts/cder/iig/index.Cfm.
   Google Scholar
• Schofield TL. Vaccine stability study design and analysis to support product licensure. Biologicals. 2009 ;37(6):387–96. doi:10.1016/j.biologicals.2009.08.009.
   PubMed Web of Science ®Google Scholar
• Kumru OS, Joshi SB, Smith DE, Middaugh CR, Prusik T, Volkin DB. Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies. Biologicals. 2014;42(5):237–59. doi:10.1016/j.biologicals.2014.05.007.
   PubMed Web of Science ®Google Scholar
• Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med. 2004;351:2295–301.  doi:10.1056/NEJMoa043540.
   Web of Science ®Google Scholar
• Abdul‐Fattah AM, Kalonia DS, Pikal MJ. The Challenge of Drying Method Selection for Protein Pharmaceuticals: product Quality Implications. J Pharm Sci. 2007;96(8):1886–916. doi:10.1002/jps.20842.
   PubMed Web of Science ®Google Scholar
• Hansen LJJ, Daoussi R, Vervaet C, Remon JP, De Beer TRM. Freeze-drying of live virus vaccines: a review. Vaccine. 2015;33(42):5507–19. doi:10.1016/j.vaccine.2015.08.085.
   PubMed Web of Science ®Google Scholar
• Burke CJ, Hsu TA, Volkin DB. Formulation, stability, and delivery of live attenuated vaccines for human use. Crit Rev Ther Drug Carrier Syst. 1999;16:1–83.
   PubMed Web of Science ®Google Scholar
• Kamerzell TJ, Esfandiary R, Joshi SB, Middaugh CR, Volkin DB. Protein–excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. Adv Drug Deliv Rev. 2011;63:1118–59.
   PubMed Web of Science ®Google Scholar
• Tian F, Middaugh CR, Offerdahl T, Munson E, Sane S, Rytting JH. Spectroscopic evaluation of the stabilization of humanized monoclonal antibodies in amino acid formulations. Int J Pharm. 2007;335(1–2):20–31. doi:10.1016/j.ijpharm.2006.10.037.
   PubMedGoogle Scholar
• Ohtake S, Martin R, Yee L, Chen D, Kristensen D, Lechuga D, Truong-Le V. Heat-stable measles vaccine produced by spray drying. Vaccine. 2010;28(5):1275–84. doi:10.1016/j.vaccine.2009.11.024.
   PubMed Web of Science ®Google Scholar
• Patel A, Erb SM, Strange L, Shukla RS, Kumru OZ, Smith L, Nelson P, Joshi SB, Livengood JA, Volkin DB. Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidate. Vaccine. 2018;36(22):3169–79. doi:10.1016/j.vaccine.2017.04.086.
   PubMed Web of Science ®Google Scholar